|
1
|
Yin C, Evason KJ, Asahina K and Stainier
DY: Hepatic stellate cells in liver development, regeneration, and
cancer. J Clin Invest. 123:1902–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Higashi T, Friedman SL and Hoshida Y:
Hepatic stellate cells as key target in liver fibrosis. Adv Drug
Deliv Rev. 121:27–42. 2017. View Article : Google Scholar
|
|
3
|
Dixon LJ, Barnes M, Tang H, Pritchard MT
and Nagy LE: Kupffer cells in the liver. Compr Physiol. 3:785–797.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koyama Y and Brenner DA: Liver
inflammation and fibrosis. J Clin Invest. 127:55–64. 2017.
View Article : Google Scholar
|
|
5
|
Dhar D, Baglieri J, Kisseleva T and
Brenner DA: Mechanisms of liver fibrosis and its role in liver
cancer. Exp Biol Med (Maywood). 245:96–108. 2020. View Article : Google Scholar
|
|
6
|
Peng H, Wan LY, Liang JJ, Zhang YQ, Ai WB
and Wu JF: The roles of lncRNA in hepatic fibrosis. Cell Biosci.
8:632018. View Article : Google Scholar :
|
|
7
|
Zhang K, Han X, Zhang Z, Zheng L, Hu Z,
Yao Q, Cui H, Shu G, Si M, Li C, et al: The liver-enriched
lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch
pathways. Nat Commun. 8:1442017. View Article : Google Scholar
|
|
8
|
Wang X, Cheng Z, Dai L, Jiang T, Jia L,
Jing X, An L, Wang H and Liu M: Knockdown of long noncoding RNA H19
represses the progress of pulmonary fibrosis through the
transforming growth factor β/smad3 pathway by regulating MicroRNA
140. Mol Cell Biol. 39:e00143–19. 2019. View Article : Google Scholar
|
|
9
|
Dooley S and ten Dijke P: TGF-β in
progression of liver disease. Cell Tissue Res. 347:245–256. 2012.
View Article : Google Scholar
|
|
10
|
Yang JW, Hien TT, Lim SC, Jun DW, Choi HS,
Yoon JH, Cho IJ and Kang KW: Pin1 induction in the fibrotic liver
and its roles in TGF-β1 expression and Smad2/3 phosphorylation. J
Hepatol. 60:1235–1241. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu Y, Liu X, Zhou Q, Huang C, Meng X, Xu F
and Li J: Silent information regulator 1 (SIRT1) ameliorates liver
fibrosis via promoting activated stellate cell apoptosis and
reversion. Toxicol Appl Pharmacol. 289:163–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang R, Zhou Y, Wang S, Pang N, Huang Y,
Ye M, Wan T, Qiu Y, Pei L, Jiang X, et al: Nicotinamide riboside
protects against liver fibrosis induced by CCl4 via
regulating the acetylation of smads signaling pathway. Life Sci.
225:20–28. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu F, Lu Z, Cai J, Huang K, Chen B, Li G,
Dong P and Zheng J: MALAT1 functions as a competing endogenous RNA
to mediate Rac1 expression by sequestering miR-101b in liver
fibrosis. Cell Cycle. 14:3885–3896. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dai X, Chen C, Xue J, Xiao T, Mostofa G,
Wang D, Chen X, Xu H, Sun Q, Li J, et al: Exosomal MALAT1 derived
from hepatic cells is involved in the activation of hepatic
stellate cells via miRNA-26b in fibrosis induced by arsenite.
Toxicol Lett. 316:73–84. 2019. View Article : Google Scholar
|
|
15
|
Sun Y, Jiang T, Jia Y, Zou J, Wang X and
Gu W: LncRNA MALAT1/miR-181a-5p affects the proliferation and
adhesion of myeloma cells via regulation of Hippo-YAP signaling
pathway. Cell Cycle. 18:2509–2523. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang K, Guo S, Zhang T, Yang Y, Zhao G,
Shaukat A, Wu H and Deng G: Downregulation of TLR4 by miR-181a
provides negative feedback regulation to lipopolysaccharide-induced
inflammation. Front Pharmacol. 9:1422018. View Article : Google Scholar :
|
|
17
|
Sahin H, Borkham-Kamphorst E, do O NT,
Berres ML, Kaldenbach M, Schmitz P, Weiskirchen R, Liedtke C,
Streetz KL, Maedler K, et al: Proapoptotic effects of the
chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in
hepatocytes. Hepatology. 57:797–805. 2013. View Article : Google Scholar
|
|
18
|
Zhu D, He X, Duan Y, Chen J, Wang J, Sun
X, Qian H, Feng J, Sun W, Xu F and Zhang L: Expression of
microRNA-454 in TGF-β1-stimulated hepatic stellate cells and in
mouse livers infected with Schistosoma japonicum. Parasit Vectors.
7:1482014. View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Lai L, Chen Y, Tian X, Li X, Zhang X, Lei
J, Bi Y, Fang B and Song X: Artesunate alleviates hepatic fibrosis
induced by multiple pathogenic factors and inflammation through the
inhibition of LPS/TLR4/NF-κB signaling pathway in rats. Eur J
Pharmacol. 765:234–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Z, Amro EM, Becker F, Hölzer M, Rasa
SMM, Njeru SN, Han B, Di Sanzo S, Chen Y, Tang D, et al:
Cohesin-mediated NF-κB signaling limits hematopoietic stem cell
self-renewal in aging and inflammation. J Exp Med. 216:152–175.
2019. View Article : Google Scholar :
|
|
22
|
Kobayashi K, Yoshioka T, Miyauchi J,
Nakazawa A, Yamazaki S, Ono H, Tatsuno M, Iijima K, Takahashi C,
Okada Y, et al: Monocyte chemoattractant protein-1 (MCP-1) as a
potential therapeutic target and a noninvasive biomarker of liver
fibrosis associated with transient myeloproliferative disorder in
down syndrome. J Pediatr Hematol Oncol. 39:e285–e289. 2017.
View Article : Google Scholar
|
|
23
|
Zimmermann HW, Seidler S, Gassler N,
Nattermann J, Luedde T, Trautwein C and Tacke F: Interleukin-8 is
activated in patients with chronic liver diseases and associated
with hepatic macrophage accumulation in human liver fibrosis. PLoS
One. 6:e213812011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vespasiani-Gentilucci U, Carotti S,
Perrone G, Mazzarelli C, Galati G, Onetti-Muda A, Picardi A and
Morini S: Hepatic toll-like receptor 4 expression is associated
with portal inflammation and fibrosis in patients with NAFLD. Liver
Int. 35:569–581. 2015. View Article : Google Scholar
|
|
25
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X, Li M, Wang Z, Han S, Tang X, Ge Y,
Zhou L, Zhou C, Yuan Q and Yang M: Silencing of long noncoding RNA
MALAT1 by miR-101 and miR-217 inhibits proliferation, migration,
and invasion of esophageal squamous cell carcinoma cells. J Biol
Chem. 290:3925–3935. 2015. View Article : Google Scholar :
|
|
27
|
Yang F, Yi F, Han X, Du Q and Liang Z:
MALAT-1 interacts with hnRNP C in cell cycle regulation. FEBS Lett.
587:3175–3181. 2013. View Article : Google Scholar
|
|
28
|
Puthanveetil P, Chen S, Feng B, Gautam A
and Chakrabarti S: Long non-coding RNA MALAT1 regulates
hyperglycaemia induced inflammatory process in the endothelial
cells. J Cell Mol Med. 19:1418–1425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao G, Su Z, Song D, Mao Y and Mao X: The
long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced
inflammatory response through its interaction with NF-κB. FEBS
Lett. 590:2884–2895. 2016. View Article : Google Scholar
|
|
30
|
Liu N, Feng J, Lu X, Yao Z, Liu Q, Lv Y,
Han Y, Deng J and Zhou Y: Isorhamnetin inhibits liver fibrosis by
reducing autophagy and inhibiting extracellular matrix formation
via the TGF-β1/smad3 and TGF-β1/p38 MAPK pathways. Mediators
Inflamm. 2019:61750912019. View Article : Google Scholar
|
|
31
|
Wang Y, Yu Y, Tsuyada A, Ren X, Wu X,
Stubblefield K, Rankin-Gee EK and Wang SE: Transforming growth
factor-β regulates the sphere-initiating stem cell-like feature in
breast cancer through miRNA-181 and ATM. Oncogene. 30:1470–1480.
2011. View Article : Google Scholar
|
|
32
|
Wang B, Hsu SH, Majumder S, Kutay H, Huang
W, Jacob ST and Ghoshal K: TGFbeta-mediated upregulation of hepatic
miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Oncogene. 29:1787–1797. 2010. View Article : Google Scholar
|
|
33
|
Neu J, Dziunycz PJ, Dzung A, Lefort K,
Falke M, Denzler R, Freiberger SN, Iotzova-Weiss G, Kuzmanov A,
Levesque MP, et al: miR-181a decelerates proliferation in cutaneous
squamous cell carcinoma by targeting the proto-oncogene KRAS. PLoS
One. 12:e01850282017. View Article : Google Scholar
|
|
34
|
Li GH, Ma ZH and Wang X: Long non-coding
RNA CCAT1 is a prognostic biomarker for the progression of oral
squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin
signaling pathway. Cell cycle. 18:2902–2913. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi Q, Zhou Z, Ye N, Chen Q, Zheng X and
Fang M: MiR-181a inhibits non-small cell lung cancer cell
proliferation by targeting CDK1. Cancer Biomark. 20:539–546. 2017.
View Article : Google Scholar
|
|
36
|
Ma J, Yao Y, Wang P, Liu Y, Zhao L, Li Z,
Li Z and Xue Y: MiR-181a regulates blood-tumor barrier permeability
by targeting Krüppel-like factor 6. J Cereb Blood Flow Metab.
34:1826–1836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Taylor MA, Sossey-Alaoui K, Thompson CL,
Danielpour D and Schiemann WP: TGF-β upregulates miR-181a
expression to promote breast cancer metastasis. J Clin Invest.
123:150–163. 2013. View Article : Google Scholar
|
|
38
|
Zhuang X, Chen Y, Wu Z, Xu Q, Chen M, Shao
M, Cao X, Zhou Y, Xie M, Shi Y, et al: Mitochondrial miR-181a-5p
promotes glucose metabolism reprogramming in liver cancer by
regulating the electron transport chain. Carcinogenesis.
41:972–983. 2020. View Article : Google Scholar
|
|
39
|
Yang C, Tabatabaei SN, Ruan X and Hardy P:
The dual regulatory role of MiR-181a in breast cancer. Cell Physiol
Biochem. 44:843–856. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Seoudi AM, Lashine YA and Abdelaziz AI:
MicroRNA-181a-a tale of discrepancies. Expert Rev Mol Med.
14:e52012. View Article : Google Scholar
|
|
41
|
Kim C, Jadhav RR, Gustafson CE, Smithey
MJ, Hirsch AJ, Uhrlaub JL, Hildebrand WH, Nikolich-Žugich J, Weyand
CM and Goronzy JJ: Defects in antiviral T cell responses inflicted
by aging-associated miR-181a deficiency. Cell Rep. 29:2202–2216.e5.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cai ZG, Zhang SM, Zhang Y, Zhou YY, Wu HB
and Xu XP: MicroRNAs are dynamically regulated and play an
important role in LPS-induced lung injury. Can J Physiol Pharmacol.
90:37–43. 2012. View Article : Google Scholar
|
|
43
|
Anthony B, Allen JT, Li YS and McManus DP:
Hepatic stellate cells and parasite-induced liver fibrosis. Parasit
Vectors. 3:602010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Parola M and Pinzani M: Liver fibrosis:
Pathophysiology, pathogenetic targets and clinical issues. Mol
Aspects Med. 65:37–55. 2019. View Article : Google Scholar
|
|
45
|
Mu M, Zuo S, Wu RM, Deng KS, Lu S, Zhu JJ,
Zou GL, Yang J, Cheng ML and Zhao XK: Ferulic acid attenuates liver
fibrosis and hepatic stellate cell activation via inhibition of
TGF-β/Smad signaling pathway. Drug Des Devel Ther. 12:4107–4115.
2018. View Article : Google Scholar
|
|
46
|
Hu N, Wang C, Dai X, Zhou M, Gong L, Yu L,
Peng C and Li Y: Phillygenin inhibits LPS-induced activation and
inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway. J
Ethnopharmacol. 248:1123612020. View Article : Google Scholar
|
